Kohl's Stock News

Kohl''s Corp. (KSS) holder and activist investor Macellum Capital is said to plan to nominate a slate of directors in order to take control of the department store chain''s board

Jonathan Duskin, Macellum Capital CEO, joins 'Closing Bell' to discuss its plans to nominate a new slate of directors at Kohl's Corp.

Kohl's says that recent offers to purchase the department store chain undervalue its business and said it's adopting a shareholder rights plan to head off any hostile takeovers.

#Kohl's Yahoo Finance's Jared Blikre examines the market and takes a look at Amazon's surging shares and Kohl's rallying stocks.

Kohl''s Corporation (NYSE: KSS ) has swatted away a pair of unsolicited inquiries for acquisition by insisting the offers were insufficient. What Happened: In a press statement, the board of directors of the Menomonee Falls, Wisconsin-based retailer said “the valuations indicated in the current expressions of interest which it has received do not adequately reflect the company’s value in light of its future growth and cash flow generation.” The board added that its finance committee would “review and pursue opportunities that it believes would credibly lead to value consistent with its performance and future opportunities.” Kohl’s also announced it adopted a limited-duration shareholder rights plan that … Full story available on Benzinga.com

Department store chain Kohl''s Corp. (KSS) gained 2.7% even after the company initially rejected multiple unsolicited bids as being too low

Kohl''s also said it has adopted a shareholder rights plan, otherwise known as a "poison pill," in order to avert a hostile takeover.

Kohl''s also said it has adopted a shareholder rights plan, otherwise known as a "poison pill," in order to avert a hostile takeover.

Kohl's Corp. ( KSS , Financial) rejected recent takeover bids from several parties on Friday, saying it believes they undervalue its business.

Kohl's shoots down a takeover offer, and investors are taking the snub in stride.

The retailer, under siege from multiple investors looking to buy the company, has rejected all the offers as inadequate

Kohl's Corporation (NYSE: KSS) has swatted away a pair of unsolicited inquiries for acquisition by insisting the offers were insufficient. What Happened: In a press statement, the board of directors o

Kohl's Corp. [s: kss] released a statement Friday stating that it is rejecting the buyout offers it received.

Kohl's also said it has adopted a shareholder rights plan, otherwise known as a "poison pill," in order to avert a hostile takeover.

Kohl's Corp said on Friday it had received buyout offers that undervalued the company as they did not reflect its future growth and cash flow generation.